Anika Therapeutics (ANIK) Assets Average: 2011-2025
Historic Assets Average for Anika Therapeutics (ANIK) over the last 14 years, with Sep 2025 value amounting to $188.6 million.
- Anika Therapeutics' Assets Average fell 23.67% to $188.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $188.6 million, marking a year-over-year decrease of 23.67%. This contributed to the annual value of $236.7 million for FY2024, which is 23.62% down from last year.
- Latest data reveals that Anika Therapeutics reported Assets Average of $188.6 million as of Q3 2025, which was down 0.31% from $189.1 million recorded in Q2 2025.
- In the past 5 years, Anika Therapeutics' Assets Average registered a high of $363.9 million during Q1 2021, and its lowest value of $188.6 million during Q3 2025.
- Its 3-year average for Assets Average is $261.4 million, with a median of $263.2 million in 2024.
- Data for Anika Therapeutics' Assets Average shows a maximum YoY declined of 28.14% (in 2025) over the last 5 years.
- Anika Therapeutics' Assets Average (Quarterly) stood at $350.2 million in 2021, then dropped by 0.51% to $348.4 million in 2022, then decreased by 14.07% to $299.4 million in 2023, then dropped by 27.50% to $217.1 million in 2024, then decreased by 23.67% to $188.6 million in 2025.
- Its Assets Average was $188.6 million in Q3 2025, compared to $189.1 million in Q2 2025 and $196.7 million in Q1 2025.